2024-515580-64-00RecruitingPhase 1/2
Phase 1b/2 trial of 5-fluorouracil, leucovorin, irinotecan in combination with temozolomide (FLIRT) and bevacizumab for the first-line treatment of patients with MGMT silenced, microsatellite stable metastatic colorectal cancer.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Dec 2025
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- First submitted
- 5 Jul 2024
- Start date
- 31 Dec 2020
- Lead sponsor
- Fondazione IRCCS Istituto Nazionale Dei Tumori
- Diseases
- Colorectal cancer
- EU CT number
- 2024-515580-64-00
- EudraCT number
- 2020-002315-22
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 33
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (6)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Azienda Unita Sanitaria Locale Della Romagna | Faenza | Italy | Recruiting |
| Fondazione IRCCS - Istituto Nazionale dei Tumori | Milan | Italy | Recruiting |
| Istituto Oncologico Veneto | Padova | Italy | Recruiting |
| Azienda Ospedaliero Universitaria Pisana | Pisa | Italy | Recruiting |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Rome | Italy | Recruiting |
| Azienda Sanitaria Universitaria Friuli Centrale | Udine | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.